Difference between revisions of "Team:UofC Calgary"

Line 296: Line 296:
 
                             </div>
 
                             </div>
 
                             <div class="col-md-8 c-no-bottom-padding">
 
                             <div class="col-md-8 c-no-bottom-padding">
                                 <div class="c-body">
+
                                 <div class="c-body" style="
 +
    padding-top: 0px;">
 
                                     <ul class="c-row">
 
                                     <ul class="c-row">
 
                                         <li class="wow animate fadeInUp" style="visibility: visible; animation-name: fadeInUp; width: 100%;" style="color:#EBDEBE">
 
                                         <li class="wow animate fadeInUp" style="visibility: visible; animation-name: fadeInUp; width: 100%;" style="color:#EBDEBE">
 
                                             <h4 style="color:#EBDEBE">Project Description</h4>
 
                                             <h4 style="color:#EBDEBE">Project Description</h4>
                                             <p>Each year on Earth, we receive 2.4 mSv of ionizing radiation. In space however without the protection of the magnetosphere, astronauts receive ionizing radiation in the range of 50 to 2000 mSv. This exposure to ionizing radiation in space causes the build-up of double strand breaks in DNA. This high energy radiation has the ability to create double stranded breaks in our DNA via multiple pathways. These breaks can cause significant damage to our DNA and if damage occurs in oncogenes or tumour suppressor genes then the likelihood of getting cancer increase a thousand fold.
+
                                             <p>Each year on Earth, individuals receive 2.4 mSv of ionizing radiation (IR), which is easily tolerated by our cells. In space however, without the protection of the magnetosphere, astronauts are exposed to high levels of IR in the range of 50 to 2000 mSv which causes the accumulation of deleterious double strand breaks in DNA. Despite current research into methods of IR protection, many solutions such as radiation shield coating are expensive. Biological solutions such as the use of radioprotectors are also subjected to the sinusoidal pharmacokinetic problem resulting in the need for constant administration and the accumulation of waste. </p> <p>
  
Research has shown that Bowman-Birk Inhibitor (BBI), a soybean derived protease inhibitor, has been found to possess radioprotective effects on DNA. Previous studies have shown that BBI suppresses carcinogenesis, increasing the survival rate of cells significantly when irradiated. BBI is also found to be an anti-cougulant, as a result it cannot be administered directly, however it can be truncated (mBBI) with only radio-protective domain present.  
+
Certain naturally-occuring proteins and peptides, such as the modified Bowman-Birk Inhibitor (mBBI), have been found to confer protection against DNA damage in cells exposed to ionizing radiation. Previous studies have shown that BBI increases the survival rate of cells significantly when irradiated, by augmenting endogenous DNA repair mechanisms. </p><p>
 +
 
 +
To solve the problem of creating a cost effective, continuous delivery system for IR protection, we have designed a transdermal patch for the delivery of mBBI through the skin. The patch hosts recombinant Bacillus subtilis that expresses a mBBI gene tagged with a transdermal tag that allows the peptide to travel through the skin layers, and into the bloodstream for dispersal throughout the body. Using B. subtilis for the production of mBBI allows for constant delivery bypassing the sinusoidal pharmacokinetic problem. Its long term, continuous delivery will also create a cost effective solution. Ultimately our transdermal delivery system allows for the administration biotherapeutics within an efficient and practical system.  
  
We are creating a transdermal delivery system, which will host B. subtilis transformed with mBBI gene tagged with a transdermal tag. This will allow the peptide to travel through the skin layers and into the bloodstream, where it will be dispersed throughout the body. Subsequently, BBI will provide radioprotection to the whole body from the ionizing radiationō. By using B. subtilis to produce the peptide instead of traditional means of delivery, it will allow constant delivery and bypasses the sinusoidal pharmacokinetic problem. This is achieved by the bacteria that are present in our patch, as they will constantly produce mBBI. Ultimately our transdermal delivery system will allow for other peptides and proteins to be delivered for the use of cell based therapeutics in space.
 
  
 
</p>
 
</p>

Revision as of 22:14, 27 June 2016

iGEM Calgary 2016

Our Project

  • Project Description

    Each year on Earth, individuals receive 2.4 mSv of ionizing radiation (IR), which is easily tolerated by our cells. In space however, without the protection of the magnetosphere, astronauts are exposed to high levels of IR in the range of 50 to 2000 mSv which causes the accumulation of deleterious double strand breaks in DNA. Despite current research into methods of IR protection, many solutions such as radiation shield coating are expensive. Biological solutions such as the use of radioprotectors are also subjected to the sinusoidal pharmacokinetic problem resulting in the need for constant administration and the accumulation of waste.

    Certain naturally-occuring proteins and peptides, such as the modified Bowman-Birk Inhibitor (mBBI), have been found to confer protection against DNA damage in cells exposed to ionizing radiation. Previous studies have shown that BBI increases the survival rate of cells significantly when irradiated, by augmenting endogenous DNA repair mechanisms.

    To solve the problem of creating a cost effective, continuous delivery system for IR protection, we have designed a transdermal patch for the delivery of mBBI through the skin. The patch hosts recombinant Bacillus subtilis that expresses a mBBI gene tagged with a transdermal tag that allows the peptide to travel through the skin layers, and into the bloodstream for dispersal throughout the body. Using B. subtilis for the production of mBBI allows for constant delivery bypassing the sinusoidal pharmacokinetic problem. Its long term, continuous delivery will also create a cost effective solution. Ultimately our transdermal delivery system allows for the administration biotherapeutics within an efficient and practical system.

Our Project

  • Radiation

    Lorem ipsum dolor sit amet consectetuer adipiscing elit sed diam nonummy nibh euismod

  • Access to Nutrients

    Lorem ipsum dolor sit amet consectetuer adipiscing elit sed diam nonummy nibh euismod

  • Resource Limitations

    Lorem ipsum dolor sit amet consectetuer adipiscing elit sed diam nonummy nibh euismod

  • Reusable Framework

    Lorem ipsum dolor sit amet consectetuer adipiscing elit sed diam nonummy nibh euismod

Escherichia coli

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed elit diam nonummy nibh euismod tincidunt ut laoreet dolore magna aluam erat volutpat. Ut wisi enim ad minim veniam quis nostrud exerci et tation diam nisl ut aliquip ex ea commodo consequat euismod tincidunt ut laoreet dolore magna aluam.

Basillus Subtilis

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed elit diam nonummy nibh euismod tincidunt ut laoreet dolore magna aluam erat volutpat. Ut wisi enim ad minim veniam quis nostrud exerci et tation diam nisl ut aliquip ex ea commodo consequat euismod tincidunt ut laoreet dolore magna aluam.

Deinococcus radiodurans

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed elit diam nonummy nibh euismod tincidunt ut laoreet dolore magna aluam erat volutpat. Ut wisi enim ad minim veniam quis nostrud exerci et tation diam nisl ut aliquip ex ea commodo consequat euismod tincidunt ut laoreet dolore magna aluam.

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed elit diam nonummy nibh euismod tincidunt ut laoreet dolore magna aluam erat volutpat. Ut wisi enim ad minim veniam quis nostrud exerci et tation diam nisl ut aliquip ex ea commodo consequat euismod tincunt ut laoreet dolore magna aluam

  • Lit af project
  • Sick lab
  • Huge fam

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed elit diam nonummy nibh euismod tincidunt ut laoreet dolore.

Our Sponsors

iGEM

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, s ed elit diam nonummy ad minim veniam quis nostrud exerci et tation diam.

Latest Entries

BBI & KTI Have Arrived!

Lorem ipsum dolor sit amet ipsum sit, consectetuer adipiscing elit sit amet

Fully Trained!

Lorem ipsum dolor ipsum sit ipsum amet, consectetuer sit adipiscing elit ipsum elit elit ipsum elit

Read More

Latest Pictures

View More

Find us

Located in Calgary, Alberta, Canada.

  • University of Calgary
  • +587 717 7233
  • syed.jafri2@ucalgary.ca